07/30/2026
Dr. Peter Kang was awarded the MDA LGMD Grant to understand in-person and remote clinical outcome measures for those living with LGMD. This project will better support hybrid trial models and overcome barriers to clinical trial participation for those living with LGMD.
Bridgebio is funding the MDA with $100,000 to advance projects aimed at improving multidisciplinary care for people with LGMD.